WJNS  Vol.3 No.4 , November 2013
Neuroimmune interaction between multiple sclerosis and inflammatory bowel disease
ABSTRACT

Inflammatory bowel disease is represented by two well-known diseases: ulcerative colitis and Crohn’s disease. These two entities have been found on multiple sclerosis patients. Although the location and clinical manifestations of these diseases are very different, their immune response patterns present many similarities. This article examines the immune pathology of inflammatory bowel disease and its relationship to the immunological behavior of multiple sclerosis.


Cite this paper
Ramirez, B. and Acosta, C. (2013) Neuroimmune interaction between multiple sclerosis and inflammatory bowel disease. World Journal of Neuroscience, 3, 199-203. doi: 10.4236/wjns.2013.34025.
References
[1]   Danzi, J.T. (1988) Extraintestinal manifestations of idiopathic inflammatory bowel disease. Archives of Internal Medicine, 148, 297-302. http://dx.doi.org/10.1001/archinte.1988.00380020041008

[2]   Stange, E.F., Travis, S.P.L., Vermeire, S., et al. (2008) European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn’s and Colitis, 2, 1-23.

[3]   Dendrinos, K., Cerda, S. and Farraye, F.A. (2008) The “cecal patch” in patients with ulcerative colitis. Gastrointestinal Endoscopy, 68, 1006-1007. http://dx.doi.org/10.1016/j.gie.2008.04.003

[4]   Baumgart, D.C. and Sandborn, W.J. (2012) Crohn’s disease. The Lancet, 380, 1590-1605.

[5]   Greenstein, A.J., Mann, D., Heimann, T., Sachar, D.B., Lachman, P. and Aufses Jr., A.H. (1987) Spontaneous free perforation and perforated abscess in 30 patients with Crohn’s disease. Annals of Surgery, 205, 72-76. http://dx.doi.org/10.1097/00000658-198701000-00013

[6]   Buccino, G.P., Corrente, G. and Visintini, D. (1994) Crohn’s disease and multiple sclerosis: A single case report. The Italian Journal of Neurological Sciences, 15, 303-306. http://dx.doi.org/10.1007/BF02339241

[7]   Pokorny, C.S., Beran, R.G. and Pokorny, M.J. (2007) Association between ulcerative colitis and multiple sclerosis. Internal Medicine Journal, 37, 721-724. http://dx.doi.org/10.1111/j.1445-5994.2007.01452.x

[8]   Schott, E., Paul, F., Wuerfel, J.T., Zipp, F., Rudolph, B., Wiedenmann, B. and Baumgart, D.C. (2007) Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. World Journal of Gastroenterology, 13, 3638-3640.

[9]   Hauser, S.L. and Oksenberg, J.R. (2006) The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron, 52, 61-76. http://dx.doi.org/10.1016/j.neuron.2006.09.011

[10]   Barnett, M.H. and Prineas, J.W. (2004) Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Annals of Neurology, 55, 458-468. http://dx.doi.org/10.1002/ana.20016

[11]   Lublin, F.D. and Reingold, S.C. (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology, 46, 907-911. http://dx.doi.org/10.1212/WNL.46.4.907

[12]   Pierik, M., Yang, H., Barmada, M.M., et al. (2006) The BID international gebetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflammatory Bowel Diseases, 11, 1-7. http://dx.doi.org/10.1097/00054725-200501000-00001

[13]   Balfour, R. (2006) Mechanisms of disease: Pathogenesis of Crohn’s disease and ulcerative colitis. Nature Clinical Practice Gastroenterology & Hepatology, 3, 390-407. http://dx.doi.org/10.1038/ncpgasthep0528

[14]   Cario, E. (2005) Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut, 54, 1182-1193. http://dx.doi.org/10.1136/gut.2004.062794

[15]   Noble, C.L., et al. (2005) The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn’s disease. Gastroenterology, 129, 1854-1864. http://dx.doi.org/10.1053/j.gastro.2005.09.025

[16]   Stoll, M., et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nature Genetics, 36, 476-480. http://dx.doi.org/10.1038/ng1345

[17]   Dubuquoy, L., et al. (2003) Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology, 124, 1265-1276. http://dx.doi.org/10.1016/S0016-5085(03)00271-3

[18]   Brant, S.R., et al. (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. The American Journal of Human Genetics, 73, 1282-1292. http://dx.doi.org/10.1086/379927

[19]   Reaves, T.A., et al. (2005) Neutrophil transepithelial migration: Role of toll-like receptors in mucosal inflamemation. Memórias do Instituto Oswaldo Cruz, 100, 191-198. http://dx.doi.org/10.1590/S0074-02762005000900033

[20]   Neurath, M.F., et al. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Medicine, 2, 998-1004. http://dx.doi.org/10.1038/nm0996-998

[21]   Schmidt, C., et al. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn’s disease but not in ulcerative colitis. Inflammatory Bowel Diseases, 11, 16-23. http://dx.doi.org/10.1097/00054725-200501000-00003

[22]   Multiple Sclerosis International Federation (2008) Atlas of MS database. Multiple Sclerosis International Federation Website. http://www.atlasofms.org/ index.aspx

[23]   Kieseier, B.C., Seifert, T., Giovannoni, G., et al. (1999) Matrix metalloproteinases in inflammatory demyelination: Targets for treatment. Neurology, 53, 20-25. http://dx.doi.org/10.1212/WNL.53.1.20

[24]   Compston, A. and Coles, A. (2002) Multiple sclerosis. Lancet, 359, 1221-1231. http://dx.doi.org/10.1016/S0140-6736(02)08220-X

[25]   Kasper, L.H. and Shoemaker, J. (2010) Multiple sclerosis immunology: The healthy immune system vs the MS immune system. Neurology, 74, S2-S8. http://dx.doi.org/10.1212/WNL.0b013e3181c97c8f

[26]   Scheid, R. and Teich, N. (2007) Neurologic manifestations of ulcerative colitis. European Journal of Neurology, 14, 483-493. http://dx.doi.org/10.1111/j.1468-1331.2007.01718.x

[27]   Purrmann, J., Arendt, G., Cleveland, S., et al. (1992) Association of Crohn’s disease and multiple sclerosis. Is there a common background? Journal of Clinical Gastroenterology, 14, 43-46. http://dx.doi.org/10.1097/00004836-199201000-00011

[28]   Rang, E.H., Brooke, B.N. and Hermon-Taylor, J. (1982) Association of ulcerative colitis and multiple sclerosis. Lancet, 2, 555. http://dx.doi.org/10.1016/S0140-6736(82)90629-8

[29]   Kimura, K., Hunter, S.F., Thollander, M.S., Loftus Jr., E.V., Melton III, L.J., O’Brien, P.C., et al. (2000) Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clinic Proceedings, 75, 802-806. http://dx.doi.org/10.4065/75.8.802

[30]   Green, C., Elliott, L., Beaudoin, C., et al. (2006) A population-based ecologic study of inflammatory bowel disease: Searching for etiologic clues. American Journal of Epidemiology, 164, 615-623. http://dx.doi.org/10.1093/aje/kwj260

[31]   Lettre, G. and Rioux, J.D. (2008) Autoimmune diseases: Insights from genome-wide association studies. Human Molecular Genetics, 17, R116-R121. http://dx.doi.org/10.1093/hmg/ddn246

[32]   De Jager, P.L., Graham, R., Farwell, L., Sawcer, S., Richardson, A., Behrens, T.W., Compston, A., Hafler, D.A., Kere, J., Vyse, T.J. and Rioux, J.D. (2006) The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus. Genes & Immunity, 7, 327-334. http://dx.doi.org/10.1038/sj.gene.6364303

[33]   Soldan, S.S., Leist, T.P., Juhng, K.N., Mc-Farland, H.F. and Jacobson, S. (2000) Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Annals of Neurology, 47, 306-313. http://dx.doi.org/10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A

[34]   Wandinger, K.P., Jabs, W., Siekhaus, A., Bubel, S., Trillenberg, P., et al. (2000) Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology, 55, 178-184. http://dx.doi.org/10.1212/WNL.55.2.178

[35]   Sriram, S., Mitchell, W. and Stratton, C. (1998) Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology, 50, 571-572. http://dx.doi.org/10.1212/WNL.50.2.571

[36]   Pucci, E., Taus, C., Cartechini, E., Morelli, M., Giuliani, G., et al. (2000) Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Annals of Neurology, 48, 399-400. http://dx.doi.org/10.1002/1531-8249(200009)48:3<399::AID-ANA20>3.0.CO;2-T

[37]   Tejada-Simon, M.V., Zang, Y.C.Q., Hong, J., Rivera, V.M. and Zhang, J.W.Z. (2003) Crossreactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Annals of Neurology, 53, 189-197. http://dx.doi.org/10.1002/ana.10425

[38]   Baker, D., O’Neill, J.K. and Turk, J.L. (1991) Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cellular Immunology, 134, 505-510. http://dx.doi.org/10.1016/0008-8749(91)90321-2

[39]   Sospedra, M. and Martin, R. (2005) Immunology of multiple sclerosis. Annual Review of Immunology, 23, 683-747. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115707

[40]   Bielekova, B., Sung, M.H., Kadom, N., Simon, R., Mc-Farland, H. and Martin, R. (2004) Expansion and functional relevance of highavidity myelin-specific CD4+ T cells in multiple sclerosis. The Journal of Immunology, 172, 3893-3904.

[41]   Morris-Downes, M.M., McCormack, K., Baker, D., Sivaprasad, D., Natkunarajah, J. and Amor, S. (2002) Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocytespecific glycoprotein (OSP) and 2’,3’-cyclic nucleotide 3’-phosphodiesterase (CNPase) in ABH and SJL mice. Journal of Neuroimmunology, 122, 20-33. http://dx.doi.org/10.1016/S0165-5728(01)00460-X

[42]   Schmidt, S., Linington, C., Zipp, F., Sotgiu, S., de Waal Malefyt, R., et al. (1997) Multiple sclerosis: Comparison of the human T-cell response to S100β and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain, 120, 1437-1445. http://dx.doi.org/10.1093/brain/120.8.1437

[43]   Bettelli, E., Pagany, M., Weiner, H.L., Linington, C., Sobel, R.A. and Kuchroo, V.K. (2003) Myelinoligoden-drocyteglycoproteinspecific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. The Journal of Experimental Medicine, 197, 1073-1081. http://dx.doi.org/10.1084/jem.20021603

[44]   Kaye, J.F., Kerlero de Rosbo, N., Mendel, I., Flechter, S., Hoffman, M., et al. (2000) The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). The Journal of Immunology, 102, 189-198. http://dx.doi.org/10.1016/S0165-5728(99)00168-X

[45]   Berger, T. and Reindl, M. (2007) Multiple sclerosis: Disease biomarkers as indicated by pathophysiology. Journal of the Neurological Sciences, 259, 21-26.

[46]   Ota, K., Matsui, M., Milford, E.L., Mackin, G.A., Weiner, H.L. and Hafler, D.A. (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature, 346, 183-187. http://dx.doi.org/10.1038/346183a0

[47]   Adalid-Peralta, L., Fragoso, G., Fleury, A. and Sciutto, E. (2011) Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections. International Journal of Biological Sciences, 7, 1412-1426. http://dx.doi.org/10.7150/ijbs.7.1412

[48]   Goodridge, H.S., Marshall, F.A., Else, K.J., Houston, K.M., Egan, C., Al-Ryami, L., Liew, F.Y., Harnett, W. and Harnett, M.M. (2005). Immunomodulation via novel use of TLR4 by the filiarial diseases. Immunological Reviews, 227, 248-263.

[49]   Ince, M.N., Elliott, D.E., Setiawan, T., Blum, A., Metwali, A., Wang, Y., Urban Jr., J.F. and Weinstock, J.V. (2006) Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. The Journal of Immunology, 176, 726-729.

[50]   Moreels, T.G., Nieuwendijk, R.J., De Man, J.G., De Winter, B.Y., Herman, A.G. and Van Marck, E.A. (2004) Concurrent infection with Schistosomamansoni attenuates inflammation induced changes in colonic morphology, cytokine levels and smooth muscle contractility of trinitrobenzenesulphonic acid induced colitis in rats. Gut, 53, 99-107. http://dx.doi.org/10.1136/gut.53.1.99

[51]   Everts, B., Smits, H.H., Hokke, C.H. and Yazdanbakhsh, M. (2010) Helminths and dendritic cells: Sensing and regulating via pattern recognition receptors, Th2 and Treg responses. European Journal of Immunology, 40, 1525-1537. http://dx.doi.org/10.1002/eji.200940109

[52]   Cantorna, M.T. (2006) Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Progress in Biophysics and Molecular Biology, 92, 60-64. http://dx.doi.org/10.1016/j.pbiomolbio.2006.02.020

 
 
Top